Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning.
Rainer KönigXueqi CaoMarcus OswaldChristina ForstnerGernot RohdeJan RuppMartin WitzenrathTobias WelteMartin KolditzMathias W Pletznull nullPublished in: The European respiratory journal (2019)
Stratifying macrolide treatment in patients following a simple treatment rule may lead to considerably reduced mortality in CAP. A future randomised controlled trial confirming our result is necessary before implementing this rule into the clinical routine.
Keyphrases
- community acquired pneumonia
- machine learning
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- study protocol
- cardiovascular events
- artificial intelligence
- randomized controlled trial
- coronary artery disease
- cardiovascular disease
- big data
- risk factors
- quality improvement
- deep learning